Key Details
Daphne Lainson
Partner
Smart & Biggar
Canada
- Chemicals
- Patents
Daphne Lainson
Overview
Daphne Lainson helps innovators secure comprehensive patent protection for their chemical, pharmaceutical and biotechnology-related inventions. With an advanced degree in chemistry, she has been entrusted with protecting inventions across the spectrum of chemical innovation. Daphne is actively involved in the AIPLA as a fellow, and she is chair of the Food and Drug Law Committee. She plays a key role as a practice leader of the firm’s life sciences practice.
Contact
Participation in Wider Community
Interviews
- Lexpert Magazine Interview - "Advancing Women in the Legal Profession", May 24, 2016
Publications
- "Coming to Canada: Information Protocol and Regulatory Issues" (co-author: Nancy Pei), BIOTECanada Insights, Spring 2016
- "Will the TPP top CETA for protection of new drugs and biologics in Canada?" (co-author: Nancy Pei), Intellectual Property Magazine, February 2016
- "Biopharmaceutical Companies Set to Benefit From International Trade Agreements" (co-author: Thuy Nguyen), Biotechnology Focus, December 2015/January 2016, p. 28
- "Major changes to Canadian IP law" (co-author: Christian Bolduc), Intellectual Property Magazine, June 2014
- "Enhanced IP rights in Canada" (co-author: Nancy P. Pei), Intellectual Property Magazine, December 2013
Professional Affiliations
- Fellow, Intellectual Property Institute of Canada
- Member, American Intellectual Property Law Association; Immediate past co-chair of the Japan Practice Committee; past Chair of the Mentoring Committee; past Chair of the Women in Intellectual Property Law Committee
- Member, Chemical Institute of Canada, Canadian Society for Chemistry
- Member, The Women's Business Network of Ottawa
- Member, Canadian Bar Association; member of the Patent Committee
Academic Affiliations
- “Patent Listing and Data Protection: A Primer for Regulatory Affairs Professionals,” (speaker), CAPRA Dinner Meeting, Dorval, QC, January 2016
- “Biosimilars are Off and Running: A Litigation and Regulatory Update” (moderator), AIPLA Annual Meeting, 2015
- "Subsequent Entry Biologics (SEBs) – Canada," AIPLA Mid-Winter meeting , Las Vegas, NV, January 2012; AIPLA webinar, March 2012
- "Making contributions visible," 3rd Annual Women in Law conference, Calgary, AB, October 2009
- "Partnerships: Policy and Research at the Crossroads: University-Industry Research Collaborations," 58th Canadian Chemical Engineering Conference, Ottawa, October 2008
